Showing results (251-260 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|April 24, 2026
Discounting Practices in Cost-Effectiveness Analyses in Dentistry: A Systematic Review of Studies Published After 2020Ramona Maruster, Michael M Bornstein, Pedram SendiClinicoeconomics and Outcomes Research : CEOR|April 2, 2026
Pharmaceutical Manufacturing in China Innovation Performance: A Dynamic QCA Analysis Based on the WSR PerspectiveWangwang Zhu, Shiqi Tao, Xiaoying Zhou, et al.Clinicoeconomics and Outcomes Research : CEOR|April 23, 2026
Healthcare Resource Utilization and the Direct Medical Cost of Fibromyalgia Patients in a Tertiary Hospital in Saudi ArabiaShiekha S AlAujan, Saja H AlMazrou, Haya A AlNahedh, et al.Clinicoeconomics and Outcomes Research : CEOR|April 22, 2026
Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD)Elena Filipova, Ivona Danova, Iana Simova, et al.Clinicoeconomics and Outcomes Research : CEOR|August 23, 2022
Predictors of Community-Based Health Insurance in Ethiopia via Multilevel Mixed-Effects Modelling: Evidence from the 2019 Ethiopia Mini Demography and Health SurveyWondesen Teshome BekeleClinicoeconomics and Outcomes Research : CEOR|September 5, 2026
Quality of Life Changes in Respiratory Infection Trajectory with Point of Care Testing During Clinical ConsultationPaula Rojas-Garcia, Reyes Lorente, Marino J González, et al.Clinicoeconomics and Outcomes Research : CEOR|July 30, 2016
Erratum: Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin [Erratum]Clinicoeconomics and Outcomes Research : CEOR|July 16, 2016
Screening strategies for active tuberculosis: focus on cost-effectivenessClaudia Caroline DoblerClinicoeconomics and Outcomes Research : CEOR|July 15, 2015
Impact of noncommunicable diseases in the State of QatarSalma Khalaf Al-Kaabi, Andrew AthertonClinicoeconomics and Outcomes Research : CEOR|June 18, 2015
Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in SpainAntoni Sicras-Mainar, Javier Rejas-Gutiérrez, Ruth Navarro-ArtiedaPageof 102